US Drug Recall Register

FDA Drug Recalls

17,898 recalls, newest first

Class II · Moderate risk Terminated

Equate Cherry Cough Drops

Reason CGMP Deviations: Potential Glass and Silicone particulates in product

Bestco LLC D-0332-2024
Class II · Moderate risk Terminated

Kroger Cherry Cough Drops

Reason CGMP Deviations: Potential Glass and Silicone particulates in product

Bestco LLC D-0330-2024
Class II · Moderate risk Terminated

Meijer Cherry Cough Drops

Reason CGMP Deviations: Potential Glass and Silicone particulates in product

Bestco LLC D-0329-2024
Class II · Moderate risk Terminated

CVS Health Cherry Cough Drops

Reason CGMP Deviations: Potential Glass and Silicone particulates in product

Bestco LLC D-0328-2024
Class II · Moderate risk Terminated

Omeza Skin Protectant

Reason CGMP Deviations

Omeza LLC D-0289-2024
Class III · Low risk Ongoing

Glimepiride Tablets

Reason Misprint on tablet

Dr. Reddy's Laboratories, Inc. D-0313-2024
Class III · Low risk Ongoing

Glimepiride Tablets

Reason Misprint on tablet

Dr. Reddy's Laboratories, Inc. D-0312-2024
Class II · Moderate risk Completed

Fexofenadine Hydrochloride Tablets

Reason CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.

Sun Pharmaceutical Industries INC NDC 51660-998-30 D-0273-2024
Class II · Moderate risk Completed

Zolpidem Tartrate Extended-Release Tablets

Reason CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.

Sun Pharmaceutical Industries INC NDC 47335-308-88 D-0272-2024
Class II · Moderate risk Completed

Zolpidem Tartrate Extended-Release Tablets

Reason CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.

Sun Pharmaceutical Industries INC NDC 47335-307-88 D-0271-2024
Class II · Moderate risk Completed

Niacin Extended-Release Tablets

Reason CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.

Sun Pharmaceutical Industries INC NDC 47335-539-81 D-0270-2024
Class II · Moderate risk Completed

Niacin Extended-Release Tablets

Reason CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.

Sun Pharmaceutical Industries INC NDC 47335-613-81 D-0269-2024
Class II · Moderate risk Completed

Mesalamine Delayed-Release Tablets

Reason CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.

Sun Pharmaceutical Industries INC NDC 63304-175-13 D-0268-2024
Class II · Moderate risk Completed

Lurasidone Hydrochloride Tablets 120mg

Reason CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.

Sun Pharmaceutical Industries INC NDC 47335-579-83 D-0267-2024
Class II · Moderate risk Completed

Lurasidone Hydrochloride Tablets 60mg

Reason CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.

Sun Pharmaceutical Industries INC NDC 47335-639-83 D-0266-2024
Class II · Moderate risk Completed

Febuxostat Tablets 80 mg

Reason CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.

Sun Pharmaceutical Industries INC NDC 47335-722-83 D-0265-2024
Class II · Moderate risk Completed

Febuxostat Tablets 40mg

Reason CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.

Sun Pharmaceutical Industries INC NDC 47335-721-83 D-0264-2024
Class II · Moderate risk Completed

Cinacalcet Tablets 60mg

Reason CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.

Sun Pharmaceutical Industries INC NDC 47335-380-83 D-0263-2024
Class II · Moderate risk Completed

Adrenalin

Reason Labeling: Incorrect or Missing Lot and/or Exp Date. The expiration date listed on the Repack Pouch Label is incorrect.

Henry Schein Inc. and Glove Club HSI Gloves Inc. NDC 42023-159-25 D-0342-2024
Class II · Moderate risk Ongoing

Hydrogen Peroxide Oral Rinse

Reason CGMP Deviations: products may not conform to the labeled specifications.

Den-Mat Holdings, LLC NDC 59883-202-16 D-0287-2024
Class II · Moderate risk Ongoing

OralProCare medicated lip treatment

Reason CGMP Deviations: products may not conform to the labeled specifications.

Den-Mat Holdings, LLC NDC 59883-500-01 D-0286-2024